Bhojwani, D. et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 32, 949–959 (2014).
Edelmann, M. N. et al. Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. Mind 137, 2973–2983 (2014).
Horowitz, T. S., Suls, J. & Trevino, M. A name for a neuroscience method to cancer-related cognitive impairment. Developments Neurosci. 41, 493–496 (2018).
Zajac-Spychala, O. et al. Lengthy-term mind structural magnetic resonance imaging and cognitive functioning in youngsters handled for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or mixed with CNS radiotherapy at decreased complete dose to 12 Gy. Neuroradiology 59, 147–156 (2017).
Zajac-Spychala, O. et al. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: influence of decreased central nervous system radiotherapy and intermediate- to high-dose methotrexate. Leuk. Lymphoma 59, 2342–2351 (2018).
Kingma, A. et al. Slight cognitive impairment and magnetic resonance imaging abnormalities however regular college ranges in youngsters handled for acute lymphoblastic leukemia with chemotherapy solely. J. Pediatr. 139, 413–420 (2001).
van der Plas, E. et al. Mind construction, working reminiscence and response inhibition in childhood leukemia Survivors. Mind Behav. 7, e00621 (2017).
Svard, D. et al. Cognitive interference processing in grownup survivors of childhood acute lymphoblastic leukemia utilizing useful magnetic resonance imaging. Acta Oncol. 61, 333–340 (2022).
Reddick, W. E., Glass, J. O., Johnson, D. P., Laningham, F. H. & Pui, C. H. Voxel-based evaluation of T2 hyperintensities in white matter throughout therapy of childhood leukemia. AJNR Am. J. Neuroradiol. 30, 1947–1954 (2009).
Reddick, W. E. et al. A quantitative MR imaging evaluation of leukoencephalopathy in youngsters handled for acute lymphoblastic leukemia with out irradiation. Am. J. Neuroradiol. 26, 2371–2377 (2005).
Vazquez, E. et al. Negative effects of oncologic therapies within the pediatric central nervous system: replace on neuroimaging findings. Radiographics 31, 1123–1139 (2011).
Fujisawa, H. et al. Methotrexate-induced subacute encephalopathy that confirmed no abnormalities on magnetic resonance imaging quickly after symptom look. Intern Med 62, 2249–2252 (2023).
McAlonan, G. White matter anisotropy in post-treatment childhood most cancers survivors: preliminary proof of affiliation with neurocognitive operate (Vol 24, Pg 884, 2006). J. Clin. Oncol. 28, 4868–4868 (2010).
Aukema, E. J. et al. White matter fractional anisotropy correlates with velocity of processing and motor velocity in younger childhood most cancers survivors. Int. J. Radiat. Oncol. Biol. Phys. 74, 837–843 (2009).
Kesler, S. R., Tanaka, H. & Koovakkattu, D. Cognitive reserve and mind volumes in pediatric acute lymphoblastic leukemia. Mind Imaging Behav. 4, 256–269 (2010).
Reddick, W. E. et al. Prognostic elements that improve the danger for decreased white matter volumes and deficits in consideration and studying for survivors of childhood cancers. Pediatr. Blood Most cancers 61, 1074–1079 (2014).
Lin, L. P. et al. Glymphatic system dysfunction in pediatric acute lymphoblastic leukemia with out clinically recognized central nervous system infiltration: a novel Dti-Alps technique. Eur. Radio. 33, 3726–3734 (2023).
Genschaft, M. et al. Influence of chemotherapy for childhood leukemia on mind morphology and performance. PLoS One 8, e78599 (2013).
Phillips, N. S. et al. Neuroanatomical abnormalities associated to dexamethasone publicity in survivors of childhood acute lymphoblastic leukemia. Pediatr. Blood Most cancers 67, e27968 (2020).
McDonald, B. C., Conroy, S. Ok., Ahles, T. A., West, J. D. & Saykin, A. J. Grey matter discount related to systemic chemotherapy for breast most cancers: a potential MRI research. Breast Most cancers Res Deal with. 123, 819–828 (2010).
McDonald, B. C., Conroy, S. Ok., Smith, D. J., West, J. D. & Saykin, A. J. Frontal grey matter discount after breast most cancers chemotherapy and affiliation with govt signs: a replication and extension research. Mind Behav. Immun. 30, S117–S125 (2013).
Gandy, Ok. et al. Structural and useful mind imaging in long-term survivors of childhood acute lymphoblastic leukemia handled with chemotherapy: a scientific overview. JNCI Most cancers Spectr. 5, pkab069 (2021).
Paakko, E. et al. White matter adjustments on mri throughout therapy in youngsters with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr. Oncol. 35, 456–461 (2000).
Wilson, D. A. et al. Transient white matter adjustments on mr photos in youngsters present process chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology 180, 205–209 (1991).
Pryweller, J. R. et al. Characterization of leukoencephalopathy and affiliation with later neurocognitive efficiency in pediatric acute lymphoblastic leukemia. Make investments Radio. 56, 117–126 (2021).
Chu, W. C. et al. White matter and cerebral metabolite adjustments in youngsters present process therapy for acute lymphoblastic leukemia: longitudinal research with mr imaging and 1h MR spectroscopy. Radiology 229, 659–669 (2003).
Ramli, N. et al. Assessing adjustments in microstructural integrity of white matter tracts in youngsters with leukaemia following publicity to chemotherapy. Pediatr. Radio. 50, 1277–1283 (2020).
Hu, Z. et al. Altered mind operate in new onset childhood acute lymphoblastic leukemia earlier than chemotherapy: a resting-state FMRI research. Mind Dev. 39, 743–750 (2017).
Wei, Ok. et al. An observational mri research of methotrexate-treated youngsters with acute lymphoblastic leukemia in remission and delicate cognitive decline. Quant. Imaging Med Surg. 12, 2474–2486 (2022).
Starvation, S. P. et al. Youngsters’s oncology group’s 2013 blueprint for analysis: acute lymphoblastic leukemia. Pediatr. Blood Most cancers 60, 957–963 (2013).
Mitchell, H. R. et al. Potential, longitudinal evaluation of high quality of life in youngsters from prognosis to three months off therapy for traditional threat acute lymphoblastic leukemia: outcomes of youngsters’s oncology group research Aall0331. Int J. Most cancers 138, 332–339 (2016).
Smith, M. et al. Uniform method to threat classification and therapy task for kids with acute lymphoblastic leukemia. J. Clin. Oncol. 14, 18–24 (1996).
Wechsler, D. Wechsler Grownup Intelligence Scale-Fourth Version (Wais-Iv) (Pearson, Bloomington, MN, 2008).
Kaufman, J. et al. Schedule for affective issues and schizophrenia for school-age children-present and lifelong model (k-sads-pl): preliminary reliability and validity information. J. Am. Acad. Little one Adolesc. Psychiatry 36, 980–988 (1997).
Poznanski, E. O., Freeman, L. N., Mokros, H. B. & Childrens Melancholy Score-Scale, – Revised (September 1984). Psychopharmacol. Bull. 21, 979–989 (1985).
DuPaul, G. J. Mum or dad and trainer scores of adhd signs: psychometric properties in a community-based pattern. J. Clin. Little one Psychol. 20, 245–253 (1991).
Constantino, J. The Social Responsiveness Scale., Western Psychological Service., (2002).
Henning, A. in Encyclopedia of Spectroscopy and Spectrometry (Third Version) (Lindon, J. C., Tranter, G. E. & Koppenaal, D. W. eds.) 192-198 (Educational Press, 2017).
Chumbley, J., Worsley, Ok., Flandin, G. & Friston, Ok. Topological FDR for neuroimaging. Neuroimage 49, 3057–3064 (2010).
Lossignol, D. Just a little assist from steroids in oncology. J. Transl. Int Med 4, 52–54 (2016).
Forster, C. et al. Occludin as direct goal for glucocorticoid-induced enchancment of blood–mind barrier properties in a murine in vitro system. J. Physiol. 565, 475–486 (2005).
Hue, C. D. et al. Dexamethasone potentiates in vitro blood-brain barrier restoration after main blast harm by glucocorticoid receptor-mediated upregulation of Zo-1 tight junction protein. J. Cereb. Blood Circulation. Metab. 35, 1191–1198 (2015).
Wolkowitz, O. M. et al. Prednisone results on blood-brain barrier permeability and CNS IGG synthesis in wholesome people. Psychoneuroendocrinology 15, 155–158 (1990).
Goriounova, N. A. et al. Giant and quick human pyramidal neurons affiliate with intelligence. Elife 7, e41714 (2018).
Cay, M. et al. Impact of improve in cortisol degree on account of stress in wholesome younger people on dynamic and static stability scores. North Clin. Istanb. 5, 295–301 (2018).
Trombetti, S. et al. Oxidative stress and ros-mediated signaling in leukemia: novel promising views to eradicate chemoresistant cells in myeloid leukemia. Int J. Mol. Sci. 22, 2470 (2021).
Hess, J. A. & Khasawneh, M. Ok. Most cancers metabolism and oxidative stress: insights into carcinogenesis and chemotherapy through the non-dihydrofolate reductase results of methotrexate. BBA Clin. 3, 152–161 (2015).
Hobl, E. L. et al. The affect of methotrexate on the gene expression of the pro-inflammatory cytokine il-12a within the remedy of rheumatoid arthritis. Clin. Exp. Rheumatol. 29, 963–969 (2011).
Cutolo, M., Sulli, A., Pizzorni, C., Seriolo, B. & Straub, R. H. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60, 729–735 (2001).
Constantin, A. et al. Antiinflammatory and immunoregulatory motion of methotrexate within the therapy of rheumatoid arthritis: proof of elevated interleukin-4 and interleukin-10 gene expression demonstrated in vitro by aggressive reverse transcriptase-polymerase chain response. Arthritis Rheum. 41, 48–57 (1998).
Neurath, M. F. et al. Methotrexate particularly modulates cytokine manufacturing by t cells and macrophages in murine collagen-induced arthritis (cia): a mechanism for methotrexate-mediated immunosuppression. Clin. Exp. Immunol. 115, 42–55 (1999).
Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L. & Bohr, V. A. DNA injury, DNA restore, getting older, and neurodegeneration. Chilly Spring Harb. Perspect. Med 5, a025130 (2015).
Dietrich, J., Han, R., Yang, Y., Mayer-Proschel, M. & Noble, M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic brokers in vitro and in vivo. J. Biol. 5, 22 (2006).
Patel, J. et al. DNA injury and mitochondria in most cancers and getting older. Carcinogenesis 41, 1625–1634 (2020).
Hoeijmakers, J. H. DNA injury, getting older, and most cancers. N. Engl. J. Med 361, 1475–1485 (2009).
Zhou, W., Kavelaars, A. & Heijnen, C. J. Metformin prevents cisplatin-induced cognitive impairment and mind injury in mice. PLoS One 11, e0151890 (2016).
Gregorios, J. B. & Soucy, D. Results of methotrexate on astrocytes in main tradition: gentle and electron microscopic research. Mind Res. 516, 20–30 (1990).
Shao, Y., Tan, B., Shi, J. & Zhou, Q. Methotrexate induces astrocyte apoptosis by disrupting folate metabolism within the mouse juvenile central nervous system. Toxicol. Lett. 301, 146–156 (2019).
Gibson, E. M. et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43–55.e13 (2019).
Perez-Figueroa, E. et al. Robust inflammatory response and th1-polarization profile in youngsters with acute lymphoblastic leukemia with out obvious an infection. Oncol. Rep. 35, 2699–2706 (2016).
Galea, I., Bechmann, I. & Perry, V. H. What Is immune privilege (not)? Developments Immunol. 28, 12–18 (2007).
Galea, I. The blood-brain barrier in systemic an infection and irritation. Cell Mol. Immunol. 18, 2489–2501 (2021).
Herkenham, M., Lee, H. Y. & Baker, R. A. Temporal and spatial patterns of C-Fos MRNA induced by intravenous interleukin-1: a cascade of non-neuronal mobile activation on the blood-brain barrier. J. Comp. Neurol. 400, 175–196 (1998).
Track, T. T. et al. Systemic pro-inflammatory response facilitates the event of cerebral edema throughout brief hypoxia. J. Neuroinflammation 13, 63 (2016).
Comim, C. M. et al. Visitors of leukocytes and cytokine up-regulation within the central nervous system in sepsis. Intensive Care Med 37, 711–718 (2011).
Cunningham, C. & Hennessy, E. Co-morbidity and systemic irritation as drivers of cognitive decline: new experimental fashions adopting a broader paradigm in dementia analysis. Alzheimer’s Res Ther. 7, 33 (2015).
Lemstra, A. W. et al. Microglia activation in sepsis: a case-control research. J. Neuroinflammation 4, 4 (2007).
Seigers, R. et al. Methotrexate reduces hippocampal blood vessel density and prompts microglia in rats however doesn’t elevate central cytokine launch. Behav. Mind Res. 207, 265–272 (2010).
Merrill, J. E. Results of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev. Neurosci. 13, 130–137 (1991).
Selmaj, Ok. W. & Raine, C. S. Tumor necrosis issue mediates myelin and oligodendrocyte injury in vitro. Ann. Neurol. 23, 339–346 (1988).
Briones, T. L. & Woods, J. Dysregulation in myelination mediated by persistent neuroinflammation: attainable mechanisms in chemotherapy-related cognitive impairment. Mind Behav. Immun. 35, 23–32 (2014).
Banno, M. et al. The unconventional scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 48, 283–290 (2005).
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J. & Lane, T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated by way of nitric oxide. J. Immunol. 151, 2132–2141 (1993).
Czapski, G. A. & Strosznajder, J. B. Glutamate and gaba in microglia-neuron cross-talk in alzheimer’s illness. Int J. Mol. Sci. 22, 11677 (2021).
Gehrmann, J., Matsumoto, Y. & Kreutzberg, G. W. Microglia: intrinsic immuneffector cell of the mind. Mind Res Mind Res Rev. 20, 269–287 (1995).
Soteros, B. M. & Sia, G. M. Complement and microglia dependent synapse elimination in mind improvement. WIREs Mech. Dis. 14, e1545 (2022).
Parker, A., Yassin, A. & Woodman, Ok. Myelitis Following Intrathecal Chemotherapy in Acute Lymphoblastic Leukemia: A Case Report. Neurology 82 (2014).
